Advances in Cancer Biology - Metastasis

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Advances in Cancer Biology - Metastasis is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,080 USD. Declared review time at DOAJ: 14 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
2667-3940
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
3,080 USD
Articles in DOAJ
164
Declared review time
14 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2021-10-22
Indexing
DOAJ
APC
3,080 USD
Declared review time (DOAJ)
14 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

164

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

14weeks

Works in OpenAlex

183

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

21

i10-index

43

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-04-27
Added to DOAJ
2021-10-22
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
69%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity1
Source type
journal
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Cancer, Hypoxia, and Metabolism
  • Circular RNAs in diseases
Show all subjects (50)
  • Cancer, Hypoxia, and Metabolism
  • Circular RNAs in diseases
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Extracellular vesicles in disease
  • Extracellular vesicles in disease
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Epigenetics and DNA Methylation
  • Immune cells in cancer
  • Cancer Research and Treatments
  • Immune cells in cancer
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Cancer Research and Treatments
  • Cancer Genomics and Diagnostics
  • Glioma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Stress, Anesthesia, and Immune Response
  • Cancer Immunotherapy and Biomarkers
  • Glioma Diagnosis and Treatment
  • Cancer Mechanisms and Therapy
  • Ferroptosis and cancer prognosis
  • Autophagy in Disease and Therapy
  • Cancer, Stress, Anesthesia, and Immune Response
  • Ferroptosis and cancer prognosis
  • Cancer Mechanisms and Therapy
  • Nanoparticle-Based Drug Delivery
  • Pancreatic and Hepatic Oncology Research
  • Ovarian cancer diagnosis and treatment
  • Autophagy in Disease and Therapy
  • Nanoplatforms for cancer theranostics
  • RNA Interference and Gene Delivery
  • Glycosylation and Glycoproteins Research
  • Cancer-related Molecular Pathways
  • Wnt/β-catenin signaling in development and cancer
  • RNA Interference and Gene Delivery
  • Glycosylation and Glycoproteins Research
  • Nanoplatforms for cancer theranostics
  • Nanoparticle-Based Drug Delivery
  • Ovarian cancer diagnosis and treatment
  • Pancreatic and Hepatic Oncology Research

Keywords (DOAJ)

  • cancer metastasis
  • metastatic progression
  • cancer cell migration and invasion
  • tumor dissemination
  • translational cancer research

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: